// App-Quantinova.ai

3106 : Outcomes of Patients with Myeloproliferative Neoplasms (MPN) after Interferon-Alpha (IFN) Therapy Discontinuation

Researchers

Presenter

  • Juliette Soret

Principal Investigators

  • Bruno Cassinat

  • Sylvie Chevret

  • Christine Dosquet

  • Stephane Giraudier

  • Emmanuelle Verger

  • Nabih Maslah

  • Nathalie Parquet

  • Christine Chomienne

  • Jean-Jacques Kiladjian

Medical Centers

  • Unite de Biologie Cellulaire, AP-HP, Hopital Saint-Louis, Paris, France

  • Clinical Investigations Center, Hopital Saint-Louis, Paris, France

  • Hospital Saint Antoine, Paris, France

  • Service de Biologie Cellulaire, Hopital Saint-Louis, APHP, paris, France

  • Hopital Saint-Louis and Paris Diderot University, Paris, France

  • Hopital Mondor, AP-HP, Creteil, France

  • Aphp Saint-Louis Hospital, Paris, France

  • Biostatistics, Hopital Saint-Louis, Paris, France

Locations

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Myeloid neoplasms

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Interferon alpha

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved